South Africa’s Healthcare Austerity Crisis is shaking the foundation of the nation’s public health system, warns the Colleges of Medicine of South Africa (CMSA). By highlighting SA’s Healthcare Austerity Crisis, the CMSA cautioned that deepening budget cuts by provincial health departments are dismantling the pipeline that produces medical specialists. The organisation says current austerity measures not only threaten the long‑term…
Category: December 2025
-
2025 Health in Review: Challenges and Triumphs
The 2025 Health in Review for the South African healthcare sector began with a seismic geopolitical shock. It is ending with a mixed scorecard of administrative failures and clinical triumphs. The tone for the year was set in January. This occurred when newly inaugurated US President Donald Trump signed an executive order pausing all foreign aid for 90 days. The…
-
Treasury Threatens Health Departments with Takeover
The National Treasury is poised to take drastic action against four provincial health departments, threatening a national takeover following reports of gross financial mismanagement and collapsing service delivery. Treasury will demand fiscal accountability from Health MECs in four key provinces. This forthcoming ultimatum forces KwaZulu-Natal, the Free State, Gauteng, and the Northern Cape to provide immediate recovery plans or yield…
-
1.4% SEP Increase Impacts Pharmaceutical Investment
The pharmaceutical sector has issued a strident, urgent plea to the Health Department. They are imploring officials to immediately reconsider the newly gazetted 1.4% SEP increase in the maximum Single Exit Price (SEP) for medicines in 2026. The adjustment, set at a mere 1.47%, is a significant blow to the industry. They had anticipated an increase more than double that…
-
Medical Scheme Increases Amidst Regulatory Concerns
For millions of South Africans grappling with the rising cost of living, the announcement that medical scheme contribution increases for 2026 will largely remain within single digits offers a welcome reprieve. However, industry experts warn that these restrained figures mask a precarious financial reality. 2026 Medical Scheme Contribution Increases: Top 5 Open Schemes Medical SchemeWeighted Average IncreaseEffective DateKey NotesBestmed6.8%1 January…
-
Wegovy Weight-Loss Pill Offers Injectables Alternative
Novo Nordisk has unveiled promising new findings from its OASIS 4 phase 3 trial. The findings suggest that a daily Wegovy weight-loss pill could serve as a highly effective alternative to the widely used injectable formulation. The pharmaceutical giant’s latest data indicates that the oral version of the drug may offer a more accessible route for patients managing obesity. This…
-
CMS Industry Report 2024: Medical Schemes Face Financial Strain
The Council for Medical Schemes (CMS) has officially released its CMS Industry Report 2024. This document offers the first fully integrated review of the sector since 2022. It merges critical data on healthcare utilisation with a comprehensive financial assessment. The findings paint a picture of an industry under significant strain. Key pressures include demographic shifts, soaring hospital costs, and a…
-
Pandemic Preparedness and Prevention: South Africa’s New Shield
As climate change accelerates the spread of pathogens worldwide, South Africa is positioning itself as a frontline defender of global health security. The nation is significantly enhancing its world-class bio-surveillance capabilities. Central to this strategy is the establishment of a new, high-tech institute: the Pandemic Preparedness and Prevention (IP3) initiative. This collaborative powerhouse is partially funded by the Department of…
-
Generic Lenacapavir Manufacturing: SA’s Bold 2027 Strategy
The South African government has unveiled an ambitious roadmap to secure the future of HIV prevention. By 2027, the state intends to facilitate generic Lenacapavir manufacturing within its borders. This move aims to address a critical supply deficit of the game-changing, twice-yearly injectable. Lenacapavir (LEN) is a potent pre-exposure prophylaxis (PrEP) agent. It was registered in South Africa in October…
-
Mediclinic Restructuring Deal: Remgro and MSC to Split Assets
Investment powerhouse Remgro and Investment Holding Limited (IHL), a subsidiary of MSC Mediterranean Shipping Company, have announced plans to restructure their joint interests in Mediclinic Holdings. The two major shareholders issued a cautionary announcement detailing an in-principle, non-binding agreement to divide key geographic assets between them. Under the proposed Mediclinic restructuring deal, Remgro will acquire 100% ownership of Mediclinic Southern…
-
GLP-1 Medicines Review: South Africa Moves to Expand Access
The National Essential Medicines List Committee (NEMLC) has officially prioritised a GLP-1 medicines review. This move signals a potential shift in how South Africa manages the dual crises of type 2 diabetes and obesity. According to senior health department officials, the review aims to determine whether these high-demand drugs should be added to the Essential Medicines List (EML). If approved,…
-
HIV Treatment Retention: South Africa’s Plan for 1.1m Patients
South Africa’s globally acclaimed response to the HIV epidemic has hit a critical “stubborn and painful” hurdle. While the nation has made massive strides in diagnosis and viral suppression, Deputy President Paul Mashatile has warned that HIV treatment retention is now the primary threat to the country’s healthcare sustainability. The Department of Health reports that 1.1 million patients stopped attending…